Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Immupeutics Medicine Technology Limited

Clinical trials sponsored by Beijing Immupeutics Medicine Technology Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New shot for tough esophageal cancer enters early human testing Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New shot for tough esophageal cancer enters early human testing

Disease control Not yet recruiting

This early-stage study tests a new drug called IPM514 in 36 people with advanced esophageal cancer that cannot be removed by surgery or has spread. The drug is given as a shot, and the main goals are to check safety and find the best dose. Researchers will also look for early sig…

Phase 1 • Sponsor: Beijing Immupeutics Medicine Technology Limited • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC